Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Shree Ganesh Biotech (India) Ltd (NSE: SHREEGANES), ISIN INE051N01026 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
SHREEGANES last traded at ₹0.44 (-2.22%), with a 52-week range of ₹0.40 to ₹0.75 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 0.00%, FIIs 1.42%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 12/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.